Clinical Trials Directory

Trials / Unknown

UnknownNCT02565550

Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To determine the efficacy of a low FODMAP diet in IBS patients and whether gut microbiota community is associated with its efficacy.

Detailed description

We seek to determine whether a low FODMAPs diet decreases symptoms in irritable bowel syndrome (IBS)patients and to identify potential microbial factors related to diet efficacy. Pain symptoms, stooling characteristics, breath hydrogen, stool microbiome will be collected and/or documented in IBS patients at baseline and during one week of an low FODMAPs intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTlow FODMAPslow FODMAPs means excluding food which contains oligosaccharides.disaccharides,monosaccharides, and polyols

Timeline

Start date
2015-07-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2015-10-01
Last updated
2015-10-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02565550. Inclusion in this directory is not an endorsement.

Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome (NCT02565550) · Clinical Trials Directory